CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 267,155 | ||
| 2023-05-31 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-05-31 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −9,478 | $125.38 | $1.2M | 5,442,468 |
| 2023-05-31 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −14,636 | $126.71 | $1.9M | 5,427,832 |
| 2023-05-31 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −11,036 | $127.84 | $1.4M | 5,416,796 |
| 2023-05-31 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −4,850 | $128.42 | $623K | 5,411,946 |
| 2023-05-31 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 307,155 | ||
| 2023-05-31 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,949 | $125.69 | $371K | 2,184,260 |
| 2023-05-31 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,373 | $126.72 | $427K | 2,180,887 |
| 2023-05-31 | AFEYAN NOUBAR Director | Sale 10b5-1 | −5,637 | $127.84 | $721K | 2,175,250 |
| 2023-05-31 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,441 | $128.55 | $314K | 2,172,809 |
| 2023-05-31 | AFEYAN NOUBAR Director | Sale 10b5-1 | −600 | $129.68 | $78K | 2,172,209 |
| 2023-05-30 | Hoge Stephen President | Sale 10b5-1 | −1,181 | $124.95 | $148K | 1,631,961 |
| 2023-05-26 | Hoge Stephen President | Exercise or conversion 10b5-1 | +2,410 | 1,633,142 | ||
| 2023-05-26 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −2,410 | 7,233 | ||
| 2023-05-25 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-05-25 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −10,367 | $126.32 | $1.3M | 5,441,579 |
| 2023-05-25 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −20,641 | $127.45 | $2.6M | 5,420,938 |
| 2023-05-25 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −8,654 | $128.33 | $1.1M | 5,412,284 |
| 2023-05-25 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −338 | $128.99 | $44K | 5,411,946 |
Page 45 of 66 · 1,314 trades